Apheresis and transplant of hematopoietic progenitor cells (HPC) from allogeneic donors of age above 60 years
Authors:
- 7 May 2012
- journal article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 47 (12) , 1520-1525
Abstract
Over the immediate past 4 years, our program has collected hematopoietic progenitor cells by apheresis from 48 individuals aged 61 and over (range 61–71 years of age). We have retrospectively analyzed the collection and transplant results associated with employing these donors, and have compared them with 175 donors aged 60 or less who were collected during the same time period. We have found no significant difference in venous access (P=0.208), rate of post-transplant engraftment of neutrophils (P=0.117) and platelets (P=0.692), or in rate and grade of acute GVHD (P=0.806). However, we have found that these older donors have a significantly lower mobilization of CD34+ cells as reflected in lower absolute counts of circulating CD34+ cells pre-apheresis (P=0.016). This, in turn, results in lower CD34+ cell yields in apheresis products (PP=0.095) to collect sufficient CD34+ cells for transplantation. We conclude that it is practical when necessary to employ donors aged 60 and above, as well as safe for both donor and intended recipient. However, concern over reduced CD34+ cell mobilization may be sufficient grounds to seek younger donors when possible.Keywords
This publication has 8 references indexed in Scilit:
- Older Age But Not Donor Health Impairs Allogeneic Granulocyte Colony-Stimulating Factor (G-CSF) Peripheral Blood Stem Cell MobilizationTransplantation and Cellular Therapy, 2009
- National Marrow Donor Program HLA Matching Guidelines for Unrelated Adult Donor Hematopoietic Cell TransplantsTransplantation and Cellular Therapy, 2008
- 116: Determining Final Apheresis Volume for Hematopoietic Progenitor Cell (HPC) Collection Based on Intra-Procedural SamplingTransplantation and Cellular Therapy, 2008
- Is there an upper age limit for bone marrow transplantation?Bone Marrow Transplantation, 2002
- CD34 cell dose in granulocyte colony-stimulating factor–mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen–identical sibling transplantationBlood, 2001
- Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor ageBlood, 2001
- Quality assurance of progenitor cell content of apheresis products: a comparison of clonogenic assays and CD34+ enumerationTransfusion Medicine, 2000
- A Convergence of Methods for a Worldwide Standard for CD34+ Cell EnumerationJournal of Hematotherapy, 1998